No Data
Innovative phar (00399.HK) will hold a board of directors meeting on November 29 to approve the mid-term performance.
Gelonghui announced on November 14 that innovative phar (00399.HK) will hold a board of directors meeting on Friday, November 29, 2024, to consider and approve (including) the consolidated interim results of the company and its subsidiaries for the six months ended September 30, 2024.
INNOVATIVE PHAR: NOTIFICATION OF BOARD MEETING
Innovative Pharmaceutical in Talks to Invest in AI Health Platform Developer
Innovative Phar intends to acquire a majority stake in Niraxx. Inc.
Innovative Phar (00399) announced that on November 12, 2024, the company, as an investor, has entered into a memorandum of understanding with the target (Niraxx. Inc.), indicating its intention to invest in the majority equity of the target. It is reported that the target is a limited company registered in Delaware, usa, mainly engaged in (a) developing the ai-driven virtual health platform SyncWell; (b) developing the brain neural technology service platform DeepSynaps; (c) integrating optical biological regulation technology into sportswear; and (d) developing
Innovative Phar (00399.HK) plans to invest in the field of AI in medical care and other areas.
Gelonghui November 12th | Innovative Phar (00399.HK) announced that on November 12, 2024, as an investor, the company has entered into a memorandum of understanding with the target, expressing its intention to invest in the majority of the target's equity. The target is a limited company registered in Delaware, usa, mainly engaged in (a) the development of the AI-driven virtual health platform SyncWell, which integrates and analyzes dispersed health data through AI applications to provide users with personalized real-time advice; (b) the development of innovative brain nerve technology service platform.
Innovative Phar (00399) intends to acquire a majority stake in Niraxx, Inc.
On November 12, 2024, innovative phar (00399) announced that the company, as an investor, has reached an agreement with...
No Data
No Data